Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIIa Trial of Baclofen for Alcohol Dependence

NCT00877734 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00877734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIIa Trial of Baclofen for Alcohol Dependence
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2005
Completion date
June 30, 2007
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence